We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Takeda Pharmaceutical said that its investigational cancer drug pevonedistat did not meet the primary endpoint of event-free survival in a phase 3 clinical trial. Read More
The FDA announced that it will hold an advisory committee meeting Sept. 17 to discuss the third booster for the Pfizer/BioNTech mRNA COVID-19 vaccine for people age 16 years and older. Read More
Two congressional Democrats are calling on the Justice Department to appeal Purdue Pharma’s $10 billion settlement that resolves lawsuits with thousands of U.S. communities and grants the company’s owners immunity from any future opioid-related lawsuits. The settlement was approved Wednesday in U.S. bankruptcy court. Read More
The FDA’s Center for Drug Evaluation and Research (CDER) has issued two newly updated manuals aimed at the agency’s staff, but useful for the regulated community as they allow a window into how FDA is planning to handle certain internal activities. Read More
Merck and Miami, Fla.-based Ridgeback Biotherapeutics are starting a phase 3 clinical trial of molnupiravir, which is intended to stop infection with COVID-19 after a person has been exposed. Read More
Pfizer began dosing yesterday in a phase 2/3 study evaluating its oral COVID-19 antiviral PF-07321332 in non-hospitalized symptomatic patients who are not at increased risk of progressing to severe disease. Read More
A New York bankruptcy judge has provisionally approved OxyContin maker Purdue Pharma’s controversial reorganization settlement, affording the family who owns the company immunity from future opioid-related litigation, a protection usually reserved for companies, not individuals. Read More
The FDA has updated its guidance on conducting clinical trials during the COVID-19 pandemic, advising sponsors to use a risk assessment to see if they need to re-monitor remotely monitored data using in-person site visits after pandemic restrictions are lifted. Read More
A county judge in Ohio has issued a court order forcing a Cincinnati hospital to give the anti-parasitic ivermectin for three weeks to a man suffering with COVID-19. Read More